FYERS
Home
/
Stocks
/
Results
/
Eiko Lifesciences Results

Eiko Lifesciences Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
--153%262%
--121%164%
--11%-6%-10%
-24%-24%-33%8%

Peer Comparison

Symbol
SOLARINDS-A
PIDILITIND-A
SRF-A
FLUOROCHEM-A
NAVINFLUOR-A
GODREJIND-A
DEEPAKNTR-A
AETHER-A
ATUL-A
AARTIIND-A
EIKO-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
19,796.3₹178446 Cr89.6172.11250.42₹1678 Cr
1,531.3₹161540 Cr60.988.5729.89₹2449 Cr
2,540.65₹75295 Cr34.8325.6102.33₹1835 Cr
4,503.65₹49109 Cr79.8520.0990.49₹577 Cr
8,470.5₹43357 Cr54.947.43184.25₹664 Cr
1,103.75₹37273 Cr31.78.4450.37₹1241 Cr
1,616.6₹22311 Cr28.4825.2974.81₹551 Cr
1,649.5₹21914 Cr93.184.7323.27₹219 Cr
6,140₹18016 Cr22.6583.32378.24₹678 Cr
485₹17812 Cr33.544.2827.98₹419 Cr
51.5₹72 Cr14.151.054.17₹5 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹11 Cr₹7 Cr₹8 Cr₹11 Cr₹84 L₹56 L₹62 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹41 L₹13 L₹32 L₹26 L₹27 L₹23 L₹9 L₹13 L₹26 L₹1 L₹5 L-₹4 L₹1 L₹5 L₹3 L₹3 L₹0₹2 L₹1 L
₹17 Cr₹18 Cr₹12 Cr₹12 Cr₹11 Cr₹12 Cr₹8 Cr₹8 Cr₹11 Cr₹85 L₹61 L₹58 L₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹88 L₹1 Cr₹1 Cr
₹15 Cr₹16 Cr₹10 Cr₹10 Cr₹9 Cr₹10 Cr₹7 Cr₹8 Cr₹11 Cr₹93 L₹46 L₹2 Cr₹5 Cr₹6 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹73 L₹55 L₹66 L-₹4 L₹18 L-₹96 L-₹1 Cr-₹2 Cr-₹39 L-₹33 L-₹12 L-₹15 L-₹9 L
₹13 L₹12 L₹7 L₹10 L₹5 L₹7 L₹3 L₹4 L₹3 L₹10 L₹70,000₹3 L₹8 L₹6 L₹7 L₹15 L₹2 L₹5 L₹4 L
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹54 L₹35 L₹46 L-₹18 L₹14 L-₹1 Cr-₹1 Cr-₹2 Cr-₹50 L-₹60 L-₹18 L-₹24 L-₹18 L
₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹40 L₹26 L₹35 L-₹13 L₹10 L-₹74 L-₹1 Cr-₹1 Cr-₹37 L-₹45 L-₹14 L-₹17 L-₹13 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2020Mar 2019Mar 2018
————
₹14 Cr₹4 Cr₹4 Cr₹4 Cr
₹43 Cr-₹87 L₹1 Cr₹2 Cr
₹43 Cr-₹87 L₹1 Cr₹2 Cr
₹57 Cr₹3 Cr₹5 Cr₹6 Cr
₹22 L-₹2 Cr-₹12 L₹22 L
₹2 Cr₹2 Cr₹42 L₹48 L
₹82 L-₹2 Cr-₹27 L₹3 L
₹3 Cr-₹2 L₹15 L₹51 L
————
₹3 Cr₹4 Cr₹1 Cr₹2 Cr
₹2 Cr₹5 Cr₹2 Cr₹1 Cr
₹76 L₹0₹94 L₹1 Cr
₹40 L₹4 L₹5 L₹6 L
₹6 Cr₹9 Cr₹4 Cr₹5 Cr
₹66 Cr₹10 Cr₹9 Cr₹11 Cr
₹3 Cr₹2 Cr₹1 Cr₹2 Cr
————
₹26 Cr₹3 Cr₹2 Cr₹2 Cr
₹3 Cr₹93 L₹74 L₹58 L
₹23 Cr₹2 Cr₹2 Cr₹2 Cr
₹7 Cr₹10 L₹2 Cr₹3 Cr
₹7 Cr₹10 L₹2 Cr₹3 Cr
₹3 Cr₹2 Cr₹5 L₹4 L
₹0₹1 Cr₹1 Cr₹8 L
₹33 Cr₹5 Cr₹5 Cr₹5 Cr
————
₹6 Cr₹3 Cr₹2 Cr₹3 Cr
₹11 Cr₹1 Cr₹86 L₹1 Cr
₹12 Cr₹2 L₹11 L₹80 L
₹23,000₹14 L₹31 L₹4 L
₹5 Cr₹47 L₹58 L₹57 L
₹33 Cr₹5 Cr₹4 Cr₹6 Cr
₹27 Cr-₹4 Cr₹9 L₹1 Cr
₹66 Cr₹10 Cr₹9 Cr₹11 Cr
₹41₹8₹13₹15
₹41₹8₹13₹15

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2020Mar 2019Mar 2018
₹3 Cr-₹5 Cr-₹100 L₹0
-₹15 L₹36 L₹34 L₹0
₹32 L₹4 Cr₹84 L₹0
₹3 Cr-₹30 L₹19 L₹0
₹3 Cr-₹33 L₹16 L₹0
-₹11 Cr-₹71 L-₹30 L₹0
₹7 Cr₹95 L-₹55 L₹0
-₹2 Cr-₹9 L-₹69 L₹0
₹13 Cr₹11 L₹80 L₹0
₹12 Cr₹2 L₹11 L₹0

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)49.15
Volume (₹)62,933.00
High (₹)52.95
Upper Circuit58.98
Low (₹)49.00
Lower Circuit39.32
Prev Close49.15
52W High (₹)64.44
Price52.33
52W Low (₹)43.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)72.01 Cr
Div. Yield (%)0.00
PE Ratio14.15
Debt to Equity0.05
Price to Book1.27
Book Value41.26
EPS (TTM)3.47
Face Value10.00
ROE (%)7.76

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDS-ANSE
PIDILITIND-ANSE
SRF-ANSE
FLUOROCHEM-ANSE
NAVINFLUOR-ANSE
GODREJIND-ANSE
DEEPAKNTR-ANSE
AETHER-ANSE
ATUL-ANSE
AARTIIND-ANSE
EIKO-XNSE
LTP
1W Low
1W High
Market cap (₹)
19515+685 (3.64%)
18735.60
20362.20
1,78,446Cr
1530-36.1 (-2.31%)
1517.30
1599.95
1,61,540Cr
2528.85-32.15 (-1.26%)
2514.80
2561
75,295Cr
4485.95-99.3 (-2.17%)
4438.55
4620
49,109Cr
8475-109.6 (-1.28%)
8360.05
8645
43,357Cr
1098.1-9.35 (-0.84%)
1090
1115.50
37,273Cr
1602.9-5.05 (-0.31%)
1572
1639.90
22,311Cr
1645+16 (0.98%)
1622
1661.50
21,914Cr
6123.4-67.2 (-1.09%)
6061.70
6231
18,016Cr
487.45-3.05 (-0.62%)
480.85
504
17,812Cr
52.33+8.17 (18.50%)
43.18
52.95
72Cr

Eiko Lifesciences Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹2.35Cr; with other income of ₹41.1Lakh, profit before interest and tax came to ₹2.1Cr. Interest expense was ₹13Lakh; PBT before exceptional items stood at ₹1.97Cr. Cost mix (full year): raw materials ₹35.04Cr; employee cost ₹34.65Lakh; depreciation ₹25.4Lakh; other expenses ₹14.81Cr. Basis: consolidated annual results.

Eiko Lifesciences Ltd Quaterly Results Key Takeaways

Eiko Lifesciences Ltd reported ₹16.75Cr total income from operations in Jun 2026, softer than ₹18.34Cr in Mar 2026 but higher than ₹10.71Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹2.35Cr; with other income of ₹41.1Lakh, profit before interest and tax came to ₹2.1Cr. Interest expense was ₹13Lakh, taking profit before tax to ₹1.97Cr. After tax of ₹49.1Lakh, profit after tax stood at ₹1.47Cr (vs ₹1.53Cr in Mar 2026 and ₹1.11Cr in Jun 2025).